Back to REGN
DUNHAM TRUST Co REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$910K
Q3 2026
Peak value
$927K
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $926K |
| Q1 2026 | $927K |
| Q2 2026 | $748K |
| Q3 2026 | $910K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $910K | 1.2K | — | — |
| Q2 2026 | $748K | 1.2K | — | — |
| Q1 2026 | $927K | 1.2K | — | — |
| Q4 2025 | $926K | 1.2K | — | — |
Other funds holding REGN
Other DUNHAM TRUST Co positions
DSGN
$111MDesign Therapeutics Inc Ordinary Shares
DSGN
$96.4MDesign Therapeutics Inc Ordinary Shares
DSGN
$81.6MDesign Therapeutics Inc Ordinary Shares
DSGN
$71.9MDesign Therapeutics Inc Ordinary Shares
CBRS
$31.6MCerebras Systems Inc Ordinary Shares - Class A
CAT
$8.6MCaterpillar Inc. Ordinary Shares
META
$7.2MMeta Platforms Inc Ordinary Shares - Class A
WFC-PZ
$7.2MWells Fargo & Co. Ordinary Shares